NCT00069719已完成2 期
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
- •logMAR visual acuity not worse than 0.6.
排除标准
- •Clinically relevant ophthalmic or systemic conditions may be excluded.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsOcular HypertensionOpen-angle GlaucomaNCT00069706Alcon Research118
已完成
3 期
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsOcular HypertensionOpen-angle GlaucomaNCT00288951Alcon Research690
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00333125Alcon Research319
已完成
2 期
RMP-A03 Ocular Suspension in Patients With PterygiumPterygiumNCT05794204Suzhou Raymon Pharmaceuticals Company, Ltd.77
已完成
4 期
Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsSubjects With Primary Open-angle Glaucoma (POAG)NCT01252888Glaukos Corporation39